Bicocca Open Archive

Logo unimib boa

Pigazzi, M., Manara, E., Buldini, B., Beqiri, V., Bisio, V., Tregnago, C., et al. (2015). Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement. HAEMATOLOGICA, 100(3), e99-e101 [10.3324/haematol.2014.114579].

Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement

Rizzari C.;
2015
Articolo in rivista - Articolo scientifico
AIEOPt(8;21); AML; AML1-ETORUNX1-RUNX1T1; CBFB-MYH11; Inv(16); Molecular MRD; Pediatric; RQ-PCR
English
2015
HAEMATOLOGICA
100
3
e99
e101
none
Pigazzi, M., Manara, E., Buldini, B., Beqiri, V., Bisio, V., Tregnago, C., et al. (2015). Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement. HAEMATOLOGICA, 100(3), e99-e101 [10.3324/haematol.2014.114579].
01 - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/336997
Citazioni
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 32
Social impact